Recap: Quotient Q2 Earnings

Shares of Quotient QTNT rose 1.7% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 56.10% over the past year to ($0.18), which beat the estimate of ($0.33).

Revenue of $16,066,000 higher by 104.77% year over year, which beat the estimate of $7,900,000.

Guidance

Quotient hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 02, 2020

Time: 08:00 AM

ET Webcast URL: https://www.quotientbd.com/media/events-and-presentations

Recent Stock Performance

Company's 52-week high was at $10.38

52-week low: $2.40

Price action over last quarter: down 31.43%

Company Overview

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the business of provision of tests with an initial focus on blood grouping and serological disease screening. The company develops and commercializes Mosaiq automation platform. Its product portfolio includes Red cell reagents, Antisera, Specialty products, Specialty kits etc. The firm operates in Edinburgh, Scotland, Eysins, Switzerland and Newton, Pennsylvania. It derives the majority of its revenue from the United States.